POYHONEN JOHN 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Jul 15, 2022
Insider Transaction Report
Form 4
POYHONEN JOHN
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-07-13−1,250→ 11,250 total→ Common Stock (1,250 underlying) - Exercise/Conversion
Restricted Stock Units
2022-07-13−4,564→ 41,628 total→ Common Stock (4,564 underlying) - Exercise/Conversion
Common Stock
2022-07-13+1,250→ 32,690 total - Exercise/Conversion
Common Stock
2022-07-13+4,564→ 37,254 total - Tax Payment
Common Stock
2022-07-13$3.01/sh−2,012$6,056→ 35,242 total
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
- [F3]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
- [F4]The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).